| dc.contributor.author | Galiana, Adrián | |
| dc.contributor.author | Olivares-Álvaro, Elena | |
| dc.contributor.author | Klett-Mingo, Mercedes | |
| dc.contributor.author | Ruiz-Roso, María Belén | |
| dc.contributor.author | Ballesteros, Sandra | |
| dc.contributor.author | de las Heras, Natalia | |
| dc.contributor.author | Fuller, Peter J | |
| dc.contributor.author | Lahera, Vicente | |
| dc.contributor.author | Martín-Fernández, Beatriz | |
| dc.date.accessioned | 2024-02-01T08:40:33Z | |
| dc.date.available | 2024-02-01T08:40:33Z | |
| dc.date.issued | 2016-08-14 | |
| dc.identifier.issn | 1873-4847 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12226/1970 | |
| dc.description.abstract | Aldosterone plays a central role in the development of cardiac pathological states involving ion transport imbalances, especially sodium transport. We have previously demonstrated a cardioprotective effect of proanthocyanidins in aldosterone-treated rats. Our objective was to investigate for the first time the effect of proanthocyanidins on serum and glucocorticoid-regulated kinase 1 (SGK1), epithelial Na+ channel (γ-ENaC), neuronal precursor cells expressed developmentally down-regulated 4-2 (Nedd4-2) and phosphoNedd4-2 protein expression in the hearts of aldosterone-treated rats. Male Wistar rats received aldosterone (1mg kg-1day-1)+1% NaCl for 3weeks. Half of the animals in each group were simultaneously treated with the proanthocyanidins-rich extract (80% w/w) (PRO80, 5mg kg-1day-1). Hypertension and diastolic dysfunction induced by aldosterone were abolished by treatment with PRO80. Expression of fibrotic, inflammatory and oxidative mediators were increased by aldosterone-salt administration and blunted by PRO80. Antioxidant capacity was improved by PRO80. The up-regulated aldosterone mediator SGK1, ENaC and p-Nedd4-2/total Nedd4-2 ratio were blocked by PRO80. PRO80 blunted aldosterone-mineralocorticoid-mediated up-regulation of ENaC provides new mechanistic insight of the beneficial effect of proanthocyanidins preventing the cardiac alterations induced by aldosterone excess. | es |
| dc.description.sponsorship | Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de España (SAF2011-30396) y al National Health and Medical Research Council (NHMRC) of Australia (1002559) | es |
| dc.language.iso | es | es |
| dc.title | Proanthocyanidins block aldosterone-dependent up-regulation of cardiac gamma ENaC and Nedd4-2 inactivation via SGK1 | es |
| dc.type | article | es |
| dc.description.course | 2015-16 | es |
| dc.journal.title | Journal of nutritional biochemistr | es |
| dc.page.initial | 13 | es |
| dc.page.final | 19 | es |
| dc.publisher.department | Departamento de Psicología y Salud | es |
| dc.publisher.faculty | Facultad de Ciencias de la Salud y de la Educación | es |
| dc.rights.accessRights | embargoedAccess | es |
| dc.subject.keyword | Aldosterone | es |
| dc.subject.keyword | Cardiac hypertrophy | es |
| dc.subject.keyword | ENaC | es |
| dc.subject.keyword | Mineralocorticoid receptor | es |
| dc.subject.keyword | Nedd4-2 | es |
| dc.subject.keyword | Proanthocyanidins | es |
| dc.subject.keyword | SGK1 | es |
| dc.volume.number | 37 | es |